CN Patent

CN101679315B — 作为d3/d2拮抗剂的哌嗪盐

Assigned to Richter Gedeon Nyrt · Expires 2013-06-12 · 13y expired

What this patent protects

本发明涉及新型的反式4-{2-[4-(2，3-二氯苯基)-哌嗪-1-基]-乙基}-N，N-二甲基氨甲酰基-环己胺的单盐酸盐、二盐酸盐、单氢溴酸盐、马来酸盐和甲磺酸盐和/或其水合物和/或溶剂合物。另外，本发明涉及所述的盐和它们的水合物和/或溶剂合物的制备方法，涉及它们在治疗和/或预防要求调节多巴胺受体的疾病中的应用以及涉及包含它们的药物组合物。

USPTO Abstract

本发明涉及新型的反式4-{2-[4-(2，3-二氯苯基)-哌嗪-1-基]-乙基}-N，N-二甲基氨甲酰基-环己胺的单盐酸盐、二盐酸盐、单氢溴酸盐、马来酸盐和甲磺酸盐和/或其水合物和/或溶剂合物。另外，本发明涉及所述的盐和它们的水合物和/或溶剂合物的制备方法，涉及它们在治疗和/或预防要求调节多巴胺受体的疾病中的应用以及涉及包含它们的药物组合物。

Drugs covered by this patent

cariprazine-hydrochloride (CARIPRAZINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN101679315B
Jurisdiction: CN
Classification: —
Expires: 2013-06-12
Drug substance claim: No
Drug product claim: No
Assignee: Richter Gedeon Nyrt
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.